Why the parasite keeps winning
And what it will take to build a vaccine that works.
Malaria kills hundreds of thousands of people every year, most of them children under five. Developing an effective vaccine has been one of the longest-running challenges in global health. OraLee Branch’s research helped explain why that challenge is so difficult—and what it will take to overcome it.
The diversity problem
Her work focused on Plasmodium falciparum, the deadliest of the malaria parasites. Specifically, she studied how the parasite’s genetic diversity varies across populations—from the high-transmission regions of western Kenya to the low-transmission river communities of the Peruvian Amazon.
This distinction matters enormously for vaccine design. A vaccine built around a single genetic variant may fail against the dozens of variants circulating in a given region. Understanding that diversity—how it’s maintained, how it shifts, how it responds to pressure—is foundational to building something that actually works.
The unexpected finding
One of her most significant findings came from a five-year longitudinal study in Peru. Despite very low transmission rates—relatively few people getting infected each year—the parasite population maintained and even amplified its genetic diversity.
This was unexpected. The conventional assumption was that low transmission would act as a bottleneck, narrowing the gene pool. Instead, her team showed that the parasites preserved a remarkably broad range of genetic variants, including in the very surface antigens that vaccines would need to target.
The implication is sobering: even in areas where malaria seems to be declining, the parasite retains the genetic toolkit to evade immune responses. Vaccine candidates must account for this diversity or risk being effective against only a fraction of circulating strains.
What the immune system learns
Her related work in Kenya’s Asembo Bay demonstrated something equally important: that low complexity of infection—being infected by fewer genetically distinct parasites—was associated with increased resistance to future malaria episodes.
This suggested that the immune system can learn from simpler infections, a finding that informs how we think about natural immunity and vaccine timing. If a simpler exposure teaches the immune system more effectively, it changes the calculus for when and how vaccines should be administered.
The second career
Around 2019, OraLee pivoted to digital health. The connection is less surprising than it seems: population-level thinking, data-driven intervention design, and health equity are threads that run through both malaria research and digital health programs.
Her digital health research produced a counterintuitive finding: adults over 65 engage with personalized coaching programs at rates exceeding those of younger users. It challenged the widespread assumption that older populations resist digital health interventions. When programs are well-designed and personalized, age isn’t a barrier—it’s an advantage.
Across 219 published papers, this body of work—from parasite genetics to digital coaching—represents a career dedicated to understanding how populations respond to intervention. The organisms changed. The scientific approach didn’t.
Read the papers
Selected publications with citation counts, organized by research phase.